Sellas Life Sciences is a late-stage biotech with no product sales, hinging on its Phase 3 REGAL trial for GPS in AML. Click ...

Wave Life Sciences (WVE) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.32 per share a year ago. These figures ...

Climate warming is increasing atmospheric evaporative demand and strengthening some measures of drought, but the consequences for water availability depend on how this climate signal propagates ...

Revolune today announced a partnership with Concept Life Sciences to help biopharma and life sciences customers reassess, transfer, and scale multiplex immunofluorescence assays using Revolune's ...

A new University of New Haven initiative brings together Health Sciences and Marine & Environmental Sciences faculty to ...

Lab leasing is showing small signs of improvement in select markets across the U.S., offering a glimmer of hope for landlords stuck in a supply glut for more than two years. But underneath the leasing ...

Wave Life Sciences (WVE) is scheduled to announce Q3 earnings results on Tuesday, October 27th, before market open. The consensus EPS Estimate is -$0.32 (flat Y/Y) and the consensus Revenue Estimate ...

Life Sciences BC (LSBC) is pleased to announce its Board of Directors following its Annual General Meeting (AGM) on October 15, 2026. The Board of Directors is comprised of life sciences leaders ...

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment of ...